Clinical Trial Update: Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

View source ↗

Summary

Clinical trial update reporting long-term usage results for Xtandi (enzalutamide) in castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Castration-resistant Prostate Cancer | Status: COMPLETED